TELA - Tela Bio Inc logo

TELA

Tela Bio Inc

TELA Bio develops and markets soft-tissue reconstruction solutions, focusing on hernia repair and abdominal wall reconstruction. Its OviTex products, made from ovine rumen and synthetic materials, are used in various surgical procedures.

โš•๏ธ Healthcare NASDAQ Listed 2019 $ USD
$1,000 invested 5 years ago โ†’$52today

Score Overview

1 Year
Score
Net Growth-6.05%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-0.46%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.1
Net Growth-23.75%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth171.21%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Score
Net Growth-83.63%
Net Trend14%
Net Income Consistency
Rev Growth417.34%
Rev Trend86%
Revenue Consistency

See the full market ranking โ†’

Tela Bio Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 18M to $ 80M and net income went from -$ 28M to -$ 38M. Revenue increased in 4 of those 5 years; net income in 1.

Tela Bio Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.72โ€”
1 Year2025-08-12
$ 1.60-54.99%
5 Years2021-08-12
$ 13.97-94.84%
All Time2019-11-08
$ 13.35-94.61%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 79M-$ 41M$ 30M
2025$ 80M-$ 38M$ 50M
2024$ 69M-$ 37M$ 52M
2023$ 58M-$ 46M$ 46M
2022$ 41M-$ 44M$ 42M
2021$ 29M-$ 33M$ 43M
2020$ 18M-$ 28M$ 74M
IPO2019$ 15M-$ 22M$ 54M

Explore beyond TELA

You're looking at Tela Bio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies